321 related articles for article (PubMed ID: 15572663)
1. Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin.
Chen HY; Shen CH; Tsai YT; Lin FC; Huang YP; Chen RH
Mol Cell Biol; 2004 Dec; 24(24):10558-72. PubMed ID: 15572663
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine phosphorylation of the CrkII adaptor protein modulates cell migration.
Takino T; Tamura M; Miyamori H; Araki M; Matsumoto K; Sato H; Yamada KM
J Cell Sci; 2003 Aug; 116(Pt 15):3145-55. PubMed ID: 12799422
[TBL] [Abstract][Full Text] [Related]
3. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.
Ostrander JH; Daniel AR; Lofgren K; Kleer CG; Lange CA
Cancer Res; 2007 May; 67(9):4199-209. PubMed ID: 17483331
[TBL] [Abstract][Full Text] [Related]
4. Coupling of RAFTK/Pyk2 kinase with c-Abl and their role in the migration of breast cancer cells.
Zrihan-Licht S; Avraham S; Jiang S; Fu Y; Avraham HK
Int J Oncol; 2004 Jan; 24(1):153-9. PubMed ID: 14654952
[TBL] [Abstract][Full Text] [Related]
5. Role of the Brk SH3 domain in substrate recognition.
Qiu H; Miller WT
Oncogene; 2004 Mar; 23(12):2216-23. PubMed ID: 14676834
[TBL] [Abstract][Full Text] [Related]
6. Breast tumor kinase phosphorylates p190RhoGAP to regulate rho and ras and promote breast carcinoma growth, migration, and invasion.
Shen CH; Chen HY; Lin MS; Li FY; Chang CC; Kuo ML; Settleman J; Chen RH
Cancer Res; 2008 Oct; 68(19):7779-87. PubMed ID: 18829532
[TBL] [Abstract][Full Text] [Related]
7. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
[TBL] [Abstract][Full Text] [Related]
8. An endogenous inhibitor of focal adhesion kinase blocks Rac1/JNK but not Ras/ERK-dependent signaling in vascular smooth muscle cells.
Sundberg LJ; Galante LM; Bill HM; Mack CP; Taylor JM
J Biol Chem; 2003 Aug; 278(32):29783-91. PubMed ID: 12782622
[TBL] [Abstract][Full Text] [Related]
9. Interaction between Brk kinase and insulin receptor substrate-4.
Qiu H; Zappacosta F; Su W; Annan RS; Miller WT
Oncogene; 2005 Aug; 24(36):5656-64. PubMed ID: 15870689
[TBL] [Abstract][Full Text] [Related]
10. The Csk homologous kinase, Chk, binds tyrosine phosphorylated paxillin in human blastic T cells.
Grgurevich S; Mikhael A; McVicar DW
Biochem Biophys Res Commun; 1999 Mar; 256(3):668-75. PubMed ID: 10080957
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine 221 in Crk regulates adhesion-dependent membrane localization of Crk and Rac and activation of Rac signaling.
Abassi YA; Vuori K
EMBO J; 2002 Sep; 21(17):4571-82. PubMed ID: 12198159
[TBL] [Abstract][Full Text] [Related]
12. Activation of Rac1 by paxillin-Crk-DOCK180 signaling complex is antagonized by Rap1 in migrating NBT-II cells.
Vallés AM; Beuvin M; Boyer B
J Biol Chem; 2004 Oct; 279(43):44490-6. PubMed ID: 15308668
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of tyrosine residues 31 and 118 on paxillin regulates cell migration through an association with CRK in NBT-II cells.
Petit V; Boyer B; Lentz D; Turner CE; Thiery JP; Vallés AM
J Cell Biol; 2000 Mar; 148(5):957-70. PubMed ID: 10704446
[TBL] [Abstract][Full Text] [Related]
14. Localized suppression of RhoA activity by Tyr31/118-phosphorylated paxillin in cell adhesion and migration.
Tsubouchi A; Sakakura J; Yagi R; Mazaki Y; Schaefer E; Yano H; Sabe H
J Cell Biol; 2002 Nov; 159(4):673-83. PubMed ID: 12446743
[TBL] [Abstract][Full Text] [Related]
15. Evidence for functional roles of Crk-II in insulin and epidermal growth factor signaling in Rat-1 fibroblasts overexpressing insulin receptors.
Ishiki M; Sasaoka T; Ishihara H; Imamura T; Usui I; Takata Y; Kobayashi M
Endocrinology; 1997 Nov; 138(11):4950-8. PubMed ID: 9348226
[TBL] [Abstract][Full Text] [Related]
16. Involvement of STAP-2 in Brk-mediated phosphorylation and activation of STAT5 in breast cancer cells.
Ikeda O; Mizushima A; Sekine Y; Yamamoto C; Muromoto R; Nanbo A; Oritani K; Yoshimura A; Matsuda T
Cancer Sci; 2011 Apr; 102(4):756-61. PubMed ID: 21205088
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of c-Crk II on the negative regulatory Tyr222 mediates nerve growth factor-induced cell spreading and morphogenesis.
Escalante M; Courtney J; Chin WG; Teng KK; Kim JI; Fajardo JE; Mayer BJ; Hempstead BL; Birge RB
J Biol Chem; 2000 Aug; 275(32):24787-97. PubMed ID: 10825157
[TBL] [Abstract][Full Text] [Related]
18. STAP-2 is phosphorylated at tyrosine-250 by Brk and modulates Brk-mediated STAT3 activation.
Ikeda O; Miyasaka Y; Sekine Y; Mizushima A; Muromoto R; Nanbo A; Yoshimura A; Matsuda T
Biochem Biophys Res Commun; 2009 Jun; 384(1):71-5. PubMed ID: 19393627
[TBL] [Abstract][Full Text] [Related]
19. Discovery, optimization, and pharmacophore modeling of oleanolic acid and analogues as breast cancer cell migration and invasion inhibitors through targeting Brk/Paxillin/Rac1 axis.
Elsayed HE; Akl MR; Ebrahim HY; Sallam AA; Haggag EG; Kamal AM; El Sayed KA
Chem Biol Drug Des; 2015 Feb; 85(2):231-43. PubMed ID: 24954090
[TBL] [Abstract][Full Text] [Related]
20. A novel adaptor-like protein which is a substrate for the non-receptor tyrosine kinase, BRK.
Mitchell PJ; Sara EA; Crompton MR
Oncogene; 2000 Aug; 19(37):4273-82. PubMed ID: 10980601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
